{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:06:59Z","timestamp":1774598819543,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,4,18]],"date-time":"2010-04-18T00:00:00Z","timestamp":1271548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00702-010-0401-z","type":"journal-article","created":{"date-parts":[[2010,4,17]],"date-time":"2010-04-17T11:29:41Z","timestamp":1271503781000},"page":"737-746","source":"Crossref","is-referenced-by-count":19,"title":["No increased chromosomal damage in l-DOPA-treated patients with Parkinson\u2019s disease: a pilot study"],"prefix":"10.1007","volume":"117","author":[{"given":"Rajaraman","family":"Gnana Oli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Walitza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helga","family":"Stopper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,18]]},"reference":[{"key":"401_CR1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrn1868","volume":"7","author":"PM Abou-Sleiman","year":"2006","unstructured":"Abou-Sleiman PM et al (2006) Expanding insights of mitochondrial dysfunction in Parkinson\u2019s disease. Nat Rev Neurosci 7:207\u2013219","journal-title":"Nat Rev Neurosci"},{"key":"401_CR2","unstructured":"Gerlach M et al (1996) Molecular mechanisms for neurodegeneration: synergism between reactive oxygen species, calcium and excitotoxic amino acids. Lippincott-Raven, Philadelphia"},{"key":"401_CR3","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","volume":"69","author":"ZI Alam","year":"1997","unstructured":"Alam ZI et al (1997) Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 69:1196\u20131203","journal-title":"J Neurochem"},{"key":"401_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-5728(01)00317-4","volume":"117","author":"F Amenta","year":"2001","unstructured":"Amenta F et al (2001) Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes. J Neuroimmunol 117:133\u2013142","journal-title":"J Neuroimmunol"},{"key":"401_CR5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1046\/j.1471-4159.1995.64020825.x","volume":"64","author":"A Basma","year":"1995","unstructured":"Basma A et al (1995) l-Dopa cytotoxicity to PC12 cells in culture is via its autoxidation. J Neurochem 64:825\u2013832","journal-title":"J Neurochem"},{"key":"401_CR6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","volume":"239","author":"IF Benzie","year":"1996","unstructured":"Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay. Anal Biochem 239:70\u201376","journal-title":"Anal Biochem"},{"key":"401_CR7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/carcin\/bgl177","volume":"28","author":"S Bonassi","year":"2007","unstructured":"Bonassi S et al (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625\u2013631","journal-title":"Carcinogenesis"},{"key":"401_CR8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/carcin\/bgn075","volume":"29","author":"S Bonassi","year":"2008","unstructured":"Bonassi S et al (2008) Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22358 subjects in 11 countries. Carcinogenesis 29:1178\u20131183","journal-title":"Carcinogenesis"},{"key":"401_CR9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jchromb.2005.10.046","volume":"830","author":"A Brink","year":"2006","unstructured":"Brink A et al (2006) Simultaneous determination of O(6)-methyl-2-deoxyguanosine, 8-oxo-7, 8-dihydro-2-deoxyguanosine, and 1, N(6)-etheno-2-deoxyadenosine in DNA using on-line sample preparation by HPLC column switching coupled to ESI-MS\/MS. J Chromatogr B Anal Technol Biomed Life Sci 830:255\u2013261","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"401_CR10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.nbd.2003.10.003","volume":"15","author":"C Buhmann","year":"2004","unstructured":"Buhmann C et al (2004) Plasma and CSF markers of oxidative stress are increased in Parkinson\u2019s disease and influenced by antiparkinsonian medication. Neurobiol Dis 15:160\u2013170","journal-title":"Neurobiol Dis"},{"key":"401_CR11","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1093\/nar\/gkm1059","volume":"35","author":"WC Burhans","year":"2007","unstructured":"Burhans WC, Weinberger M (2007) DNA replication stress, genome instability and aging. Nucleic Acids Res 35:7545\u20137556","journal-title":"Nucleic Acids Res"},{"key":"401_CR12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/ijms9050789","volume":"9","author":"RJ Castellani","year":"2008","unstructured":"Castellani RJ et al (2008) Sublethal RNA oxidation as a mechanism for neurodegenerative disease. Int J Mol Sci 9:789\u2013806","journal-title":"Int J Mol Sci"},{"key":"401_CR13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.freeradbiomed.2007.10.003","volume":"44","author":"MR Chao","year":"2008","unstructured":"Chao MR et al (2008) Prevention of artifactual oxidation in determination of cellular 8-oxo-7, 8-dihydro-2\u2032-deoxyguanosine by isotope-dilution LC\u2013MS\/MS with automated solid-phase extraction. Free Radic Biol Med 44:464\u2013473","journal-title":"Free Radic Biol Med"},{"key":"401_CR14","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0021-9258(18)48474-8","volume":"267","author":"KC Cheng","year":"1992","unstructured":"Cheng KC et al (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G\u2013T and A\u2013C substitutions. J Biol Chem 267:166\u2013172","journal-title":"J Biol Chem"},{"key":"401_CR15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10565-008-9086-6","volume":"25","author":"T Cornetta","year":"2009","unstructured":"Cornetta T et al (2009) Levodopa therapy reduces DNA damage in peripheral blood cells of patients with Parkinson\u2019s disease. Cell Biol Toxicol 25:321\u2013330","journal-title":"Cell Biol Toxicol"},{"key":"401_CR16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909","journal-title":"Neuron"},{"key":"401_CR17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","volume":"62","author":"MC Rijk De","year":"1997","unstructured":"De Rijk MC et al (1997) Prevalence of parkinsonism and Parkinson\u2019s disease in Europe: The EUROPARKINSON collaborative study. J Neurol Neurosurg Psychiatry 62:10\u201315","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"401_CR18","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","volume":"351","author":"S Fahn","year":"2004","unstructured":"Fahn S et al (2004) Levodopa and the progression of Parkinson\u2019s disease. N Engl J Med 351:2498\u20132508","journal-title":"N Engl J Med"},{"key":"401_CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-1161(94)90050-7","volume":"313","author":"M Fenech","year":"1994","unstructured":"Fenech M et al (1994) Sex is an important variable affecting spontaneous micronucleus frequency in cytokinesis-blocked lymphocytes. Mutat Res 313:203\u2013207","journal-title":"Mutat Res"},{"key":"401_CR20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1383-5718(02)00249-8","volume":"534","author":"M Fenech","year":"2003","unstructured":"Fenech M et al (2003) HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534:65\u201375","journal-title":"Mutat Res"},{"key":"401_CR21","doi-asserted-by":"crossref","first-page":"11267","DOI":"10.1016\/S0021-9258(19)49906-7","volume":"267","author":"HW Gaugitsch","year":"1992","unstructured":"Gaugitsch HW et al (1992) A novel transiently expressed, integral membrane protein linked to cell activation molecular cloning via the rapid degradation signal AUUUA. J Biol Chem 267:11267\u201311273","journal-title":"J Biol Chem"},{"key":"401_CR22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-3-211-45295-0_21","volume":"70","author":"M Gerlach","year":"2006","unstructured":"Gerlach M et al (2006) Potential sources of increased iron in the substantia nigra of parkinsonian patients. J Neural Transm Suppl 70:133\u2013142","journal-title":"J Neural Transm Suppl"},{"key":"401_CR23","first-page":"3","volume":"66","author":"H Gester","year":"1996","unstructured":"Gester H (1996) Intermediate cancer biomarkers and their use in \u03b2-carotene studies in humans. Int J Vitam Nutr Res 66:3\u201318","journal-title":"Int J Vitam Nutr Res"},{"key":"401_CR24","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/nar\/12.4.2137","volume":"12","author":"H Kasai","year":"1984","unstructured":"Kasai H, Nishimura S (1984) Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 12:2137\u20132145","journal-title":"Nucleic Acids Res"},{"key":"401_CR25","first-page":"317","volume":"45","author":"W Koller","year":"1987","unstructured":"Koller W et al (1987) Relationship of aging to Parkinson\u2019s disease. Adv Neurol 45:317\u2013321","journal-title":"Adv Neurol"},{"key":"401_CR26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00726-001-0110-x","volume":"23","author":"RM Kostrzewa","year":"2002","unstructured":"Kostrzewa RM et al (2002) Neuroprotective and neurotoxic roles of levodopa (l-DOPA) in neurodegenerative disorders relating to Parkinson\u2019s disease. Amino Acids 23:57\u201363","journal-title":"Amino Acids"},{"key":"401_CR27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s007020070030","volume":"107","author":"W Le","year":"2000","unstructured":"Le W, Jankovic J, Xie W, Appel S (2000) Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection. J Neural Transm 107:1165\u20131173","journal-title":"J Neural Transm"},{"key":"401_CR28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/362709a0","volume":"362","author":"T Lindahl","year":"1993","unstructured":"Lindahl T (1993) Instability and decay of the primary structure of DNA. Nature 362:709\u2013715","journal-title":"Nature"},{"key":"401_CR29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00207507","volume":"74","author":"S Loft","year":"1996","unstructured":"Loft S, Poulsen HE (1996) Cancer risk and oxidative DNA damage in man. J Mol Med 74:297\u2013312","journal-title":"J Mol Med"},{"key":"401_CR30","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/carcin\/13.12.2241","volume":"13","author":"S Loft","year":"1992","unstructured":"Loft S et al (1992) Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 13:2241\u20132247","journal-title":"Carcinogenesis"},{"key":"401_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1383-5718(99)00034-0","volume":"441","author":"S Loft","year":"1999","unstructured":"Loft S, Poulsen HE et al (1999) Increased urinary excretion of 8-oxo-2\u2032-deoxyguanosine, a biomarker of oxidative DNA damage, in urban bus drivers. Mutat Res 441:11\u201319","journal-title":"Mutat Res"},{"key":"401_CR32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1539\/joh.L7144","volume":"50","author":"Y Matsumoto","year":"2008","unstructured":"Matsumoto Y, Ogawa Y et al (2008) The stability of the oxidative stress marker, urinary 8-hydroxy-2\u2032- deoxyguanosine (8-OHdG), when stored at room temperature. J Occup Health 50:366\u2013372","journal-title":"J Occup Health"},{"key":"401_CR33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0891-5849(98)00302-5","volume":"26","author":"MR McCall","year":"1999","unstructured":"McCall MR, Frei B (1999) Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radical Biol Med 26:1034\u20131053","journal-title":"Free Radical Biol Med"},{"key":"401_CR34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/em.2850110413","volume":"11","author":"DB McGregor","year":"1988","unstructured":"McGregor DB et al (1988) Reactivity of catecholamines and related substances in the mouse lymphoma L5178Y cell assay for mutagens. Environ Mol Mutagen 11:523\u2013544","journal-title":"Environ Mol Mutagen"},{"key":"401_CR35","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1212\/WNL.58.12.1809","volume":"58","author":"L Migliore","year":"2002","unstructured":"Migliore L et al (2002) Oxidative damage and cytogenetic analysis in leukocytes of Parkinson\u2019s disease patients. Neurology 58:1809\u20131815","journal-title":"Neurology"},{"key":"401_CR36","first-page":"3553","volume":"81","author":"NR Musso","year":"1996","unstructured":"Musso NR et al (1996) Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes. J Clin Endocrinol Metab 81:3553\u20133557","journal-title":"J Clin Endocrinol Metab"},{"key":"401_CR37","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1471-4159.1993.tb13642.x","volume":"61","author":"C Mytilineou","year":"1993","unstructured":"Mytilineou C et al (1993) Toxic and protective effects of l-dopa on mesencephalic cell cultures. J Neurochem 61:1470\u20131478","journal-title":"J Neurochem"},{"key":"401_CR38","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/jnr.21191","volume":"85","author":"Y Nakabeppu","year":"2007","unstructured":"Nakabeppu Y et al (2007) Oxidative damage in nucleic acids and Parkinson\u2019s disease. J Neurosci Res 85:919\u2013934","journal-title":"J Neurosci Res"},{"key":"401_CR39","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1471-4159.1984.tb12834.x","volume":"43","author":"TL Perry","year":"1984","unstructured":"Perry TL et al (1984) Nigrostriatal dopaminergic neurons remain undamaged in rats given high doses of l-DOPA and carbidopa chronically. J Neurochem 43:990\u2013993","journal-title":"J Neurochem"},{"key":"401_CR40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2006.01.013","volume":"23","author":"A Prigione","year":"2006","unstructured":"Prigione A et al (2006) Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson\u2019s disease: negative correlation with levodopa dosage. Neurobiol Dis 23:36\u201343","journal-title":"Neurobiol Dis"},{"key":"401_CR41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mds.870010109","volume":"1","author":"N Quinn","year":"1986","unstructured":"Quinn N et al (1986) Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2\u00a0kg) plus decarboxylase inhibitor over a four-year period. Mov Disord 1:65\u201368","journal-title":"Mov Disord"},{"key":"401_CR42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000083579","volume":"12","author":"C Rajda","year":"2005","unstructured":"Rajda C et al (2005) Increased dopamine content in lymphocytes from high-dose l-Dopa-treated Parkinson\u2019s disease patients. Neuroimmunomodulation 12:81\u201384","journal-title":"Neuroimmunomodulation"},{"key":"401_CR43","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/carcin\/23.11.1911","volume":"23","author":"JL Ravanat","year":"2002","unstructured":"Ravanat JL et al (2002) Cellular background level of 8-oxo-7, 8-dihydro-2\u2032-deoxyguanosine: an isotope based method to evaluate artifactual oxidation of DNA during its extraction and subsequent work-up. Carcinogenesis 23:1911\u20131918","journal-title":"Carcinogenesis"},{"key":"401_CR44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/rcm.883","volume":"17","author":"R Singh","year":"2003","unstructured":"Singh R et al (2003) An improved liquid chromatography\/tandem mass spectrometry method for the determination of 8-oxo-7, 8-dihydro-2-deoxyguanosine in DNA samples using immunoaffinity column purification. Rapid Commun Mass Spectrom 17:126\u2013134","journal-title":"Rapid Commun Mass Spectrom"},{"key":"401_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0027-5107(98)00117-1","volume":"405","author":"RD Snyder","year":"1998","unstructured":"Snyder RD, Friedman MB (1998) Enhancement of cytotoxicity and clastogenicity of l-DOPA and dopamine by manganese and copper. Mutat Res 405:1\u20138","journal-title":"Mutat Res"},{"key":"401_CR46","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.tiv.2009.03.001","volume":"23","author":"H Stopper","year":"2009","unstructured":"Stopper H et al (2009) Genotoxicity of the neurotransmitter dopamine in vitro. Toxicol In Vitro 23:640\u2013646","journal-title":"Toxicol In Vitro"},{"key":"401_CR47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10875-004-6243-4","volume":"24","author":"J Vitte","year":"2004","unstructured":"Vitte J et al (2004) Oxidative stress level in circulating neutrophils is linked to neurodegenerative diseases. J Clin Immunol 24:683\u2013692","journal-title":"J Clin Immunol"},{"key":"401_CR51","unstructured":"Wessa P (2009) Spearman Rank Correlation (v1.0.0) in Free Statistics Software (v1.1.23-r6), Office for Research Development and Education. URL: http:\/\/www.wessa.net\/rwasp_spearman.wasp\/"},{"key":"401_CR48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1447-0756.1996.tb00989.x","volume":"22","author":"T Yamamoto","year":"1996","unstructured":"Yamamoto T, Hosokawa K et al (1996) Urinary 8-hydroxy-2\u2032-deoxyguanosine (8-OHdG) levels in women with or without gynecologic cancer. J Obstet Gynaecol Res 22:359\u2013363","journal-title":"J Obstet Gynaecol Res"},{"key":"401_CR49","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.freeradbiomed.2009.02.006","volume":"49","author":"NH Zawia","year":"2009","unstructured":"Zawia NH et al (2009) Epigenetics, oxidative stress, and Alzheimer disease. Free Radical Biol Med 49:1241\u20131249","journal-title":"Free Radical Biol Med"},{"key":"401_CR50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s007020170013","volume":"108","author":"BY Zeng","year":"2001","unstructured":"Zeng BY et al (2001) Chronic high dose l-dopa treatment does not alter the levels of dopamine D-1, D-2 or D-3 receptor in the striatum of normal monkeys: an autoradiographic study. J Neural Transm 108:925\u2013941","journal-title":"J Neural Transm"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0401-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-010-0401-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0401-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T06:51:40Z","timestamp":1635231100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-010-0401-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,18]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["401"],"URL":"https:\/\/doi.org\/10.1007\/s00702-010-0401-z","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,18]]}}}